| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | 114VP6C6ES |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tumor necrosis factor ligand superfamily member 13B inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glomerulonephritis, IGA | 3 | D005922 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 3 | D008180 | ClinicalTrials |
| Purpura, Thrombocytopenic, Idiopathic | 2 | D016553 | ClinicalTrials |
| Granulomatosis with Polyangiitis | 2 | D014890 | ClinicalTrials |
| Microscopic Polyangiitis | 2 | D055953 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1236126-45-6 |
| ChEMBL | CHEMBL2107877 |
| FDA SRS | 114VP6C6ES |
| Guide to Pharmacology | 9518 |
CONTENTS